Skip to content

US · ALHC · MEDICAL - HEALTHCARE PLANS

Alignment Healthcare, Inc. (ALHC) intrinsic value and stock valuation

$6.37as of 2026-11-21 · Mkt cap 2.84B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Alignment Healthcare, Inc. DCF and intrinsic value

InvestorsCraft values ALHC with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from ALHC’s statements →

Alignment Healthcare, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Plans Orange, CA 92868 alignmenthealth.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$3.95B+32.7% 5y CAGRd
20192025
Net income
-$-720K
20192025
Free cash flow
$113.2M
20192025
Total equity
$179.3M+42.4% 5y CAGRd
20192025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$3.95B$2.7B$1.82B$1.43B$1.17B
Operating income$14.8M-$-101.56M-$-127.82M-$-128.64M-$-178.07M
Net income-$-720K-$-128.03M-$-148.02M-$-149.55M-$-195.29M
EPSd-$-3.64K-$-671.05K-$-794.91K-$-825.29K-$-1.14M
Operating cash flow$139.9M$34.8M-$-59.19M-$-45.43M-$-78.78M
Capital expenditure-$-26.78M-$-41.42M-$-35.99M-$-23.77M-$-18.36M
Free cash flow$113.2M-$-6.65M-$-95.18M-$-69.2M-$-97.14M
Total assets$1.07B$782.1M$591.9M$633.9M$630.9M
Total debt$329.6M$329.3M$170.8M$164.6M$157.6M
Net debt-$-246.17M-$-103.6M-$-32.12M-$-244.95M-$-309M
Total equity$179.3M$101M$158.1M$239.3M$306.1M
Cash and short-term investments$604.2M$470.7M$318.8M$409.6M$466.6M
Income statement
20252024202320222021
Revenue$3.95B$2.7B$1.82B$1.43B$1.17B
Cost of revenue$3.46B$2.41B$1.62B$1.25B$1.04B
Gross profit$488.6M$296.7M$201M$184.3M$128.7M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$0.00$371.4M$307.4M$295.7M$291M
Other expenses$473.8M$26.9M$21.4M$17.3M$15.8M
Operating expenses$473.8M$398.3M$328.9M$312.9M$306.8M
Cost and expenses$3.93B$2.81B$1.95B$1.56B$1.35B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$15.8M$23.6M$21.2M$18.3M$17.4M
Depreciation and amortization$30.5M$27.1M$21.7M$17.5M$16M
Ebitda$45.3M-$-77.44M-$-105.3M-$-113.53M-$-161.81M
Operating income$14.8M-$-101.56M-$-127.82M-$-128.64M-$-178.07M
Total other income/expenses, net-$-15.71M-$-26.5M-$-20.38M-$-20.66M-$-17.21M
Income before tax-$-960K-$-128.05M-$-148.19M-$-149.3M-$-195.29M
Income tax expense$20K$20K-$-20K$340K$0.00
Net income-$-720K-$-128.03M-$-148.02M-$-149.55M-$-195.29M
Weighted average shares outstanding$198M$190.8M$186.2M$181.2M$172M
Weighted average diluted shares outstanding$198M$190.8M$186.2M$181.2M$172M
Balance sheet
20252024202320222021
Cash and short-term investments$604.2M$470.7M$318.8M$409.6M$466.6M
Net receivables$253.2M$153.9M$119.8M$92.9M$58.5M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$951.6M$661.6M$483.5M$544.6M$552.9M
Property, plant and equipment, net$71.3M$75M$61.9M$43M$38.2M
Goodwill and intangible assets$36.6M$39.4M$40.1M$40.3M$35.1M
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$114.2M$120.4M$108.3M$89.3M$78M
Total assets$1.07B$782.1M$591.9M$633.9M$630.9M
Accounts payable$415.7M$242.5M$170.1M$171.9M$17.4M
Short-term debt$0.00$1.21M$0.00$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$556.9M$351.9M$263M$230M$167.3M
Long-term debt$329.6M$329.3M$170.8M$164.6M$157.6M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$329.6M$329.3M$170.8M$164.6M$157.6M
Capital lease obligations$6.47M$7.83M$8.97M$3.7M$6.97M
Total liabilities$886.5M$681.1M$433.8M$394.6M$324.8M
Common stock$200K$190K$190K$190K$190K
Retained earnings-$-1.01B-$-1.01B-$-880.26M-$-732.24M-$-582.69M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$179.3M$101M$158.1M$239.3M$306.1M
Total investments$28.4M$37.8M$115.9M$0.00$0.00
Total debt$329.6M$329.3M$170.8M$164.6M$157.6M
Net debt-$-246.17M-$-103.6M-$-32.12M-$-244.95M-$-309M
Cash flow statement
20252024202320222021
Net income-$-980K-$-128.07M-$-148.17M-$-149.64M-$-195.29M
Depreciation and amortization$30.5M$27.1M$21.7M$17.5M$16M
Stock-based compensation$62.1M$71.1M$66.8M$81.7M$110.6M
Change in working capital$45.5M$60.9M$2.03M-$-5.55M-$-19.42M
Accounts receivable-$-100.11M-$-34.28M-$-26.95M-$-34.38M-$-17.61M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$10.4M-$-1.46M-$-6.35M$13.7M$440K
Net cash provided by operating activities$139.9M$34.8M-$-59.19M-$-45.43M-$-78.78M
Investments in property, plant and equipment-$-26.78M-$-41.42M-$-35.99M-$-23.77M-$-18.36M
Acquisitions, net$1.06M$0.00$0.00-$-4.04M$0.00
Net cash used for investing activities-$-14.97M$39.2M-$-147.26M-$-28.22M-$-20.82M
Common stock issued$18.1M$150K$0.00$0.00$390.6M
Common stock repurchased$0.00$0.00$0.00$0.00-$-1.47M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$18M$156M$100K$16.6M$360.1M
Net change in cash$143M$230M-$-206.34M-$-57.05M$260.5M
Cash at end of period$577.9M$434.9M$205M$411.3M$468.4M
Operating cash flow$139.9M$34.8M-$-59.19M-$-45.43M-$-78.78M
Capital expenditure-$-26.78M-$-41.42M-$-35.99M-$-23.77M-$-18.36M
Free cash flow$113.2M-$-6.65M-$-95.18M-$-69.2M-$-97.14M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Alignment Healthcare, Inc.

        Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.

        CEO
        John E. Kao
        Employees
        1.85K
        Beta
        1.05

        Explore

        Frequently asked questions

        What is the intrinsic value of Alignment Healthcare, Inc. (ALHC)?

        Alignment Healthcare, Inc. (ALHC) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is ALHC undervalued?

        ALHC trades at a price of $6.37 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.